“Design, Synthesis and Evaluation of CNS Depressant Activity of 2-(Substituted Aryl)-Piperazine-3-Phenyl-4(3H)-Quinazolinone”, Int. J. Pharm. Sci. Drug Res., vol. 15, no. 2, pp. 209–213, Mar. 2023, doi: 10.25004/IJPSDR.2023.150213.